Stroke as fatal complication of ovarian hyperstimulation syndrome

ISSN: 2147-0634
Yayın Aralığı: Yılda 4 Sayı
Başlangıç: 2012
Yayıncı: Effect Publishing Agency ( EPA )

Ovarian hyperstimulation syndrome is a condition related to injectable hormonal medications used for stimulation the maturation of oocytes in infertility caused by lack of or delayed ovarian maturation. The incidence increased due to wide spread expansion of hormonal stimulation use. The scale of symptoms of this condition varies from mild outpatient managed symptoms as vomiting and bloating to sever fatal complication as hemocon centration, fluid overload, hypercoagulability, and multisystem organ failure. The main point of management is prevention and exclude the candidates with elevated risk of the condition. Here we present a case of 30-year-old woman who had ovarian hyperstimulation syndrome with rare but severe complications.

PDF

___

Whelan JG 3rd, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril 2000;73:883-96.

Evbuomwan IO, Davison JM, Murdoch AP. Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox. Fertil Steril 2000;74:67-72.

Golan A, Ron-el R, Herman A, et al. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989;44:430-40.

Brinsden PR, Wada I, Tan SL, et al. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol. 1995;102:767-72.

Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin- releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev. 2006;3:CD001750.

Speroff L, Fritz M. 7th ed. Philadelphia, Pa: Lippincott Williams and Wilkins; 2004. Clinical Gynecological Endocrinolgy and Infertility; pp. 1999–200.

Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment. Fertil Steril. 1992;58:249–61.